DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

Provided By GlobeNewswire

Last update: Jun 3, 2025

Châtillon, France, June 03, 2025

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the “Company”), today announced today the filing of an addendum to the 2024 Universal Registration Document (the “Addendum”) with the French market authority, “Autorité des Marchés Financiers” (“AMF”).